share_log
Reuters ·  Dec 17 21:12

$Teva Pharmaceutical Industries (TEVA.US)$ up 21% Premarket After Co's Bowel Disease Drug With $Sanofi (SNY.US)$ Meets Main Goals in Mid-Stage Trial

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment